Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-09
2011-08-09
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S199000
Reexamination Certificate
active
07994196
ABSTRACT:
The present invention can provide a cancer treatment drug containing, as an active ingredient, a substance selected from the group consisting of an indazole compound of the following formula (I), a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate:
REFERENCES:
patent: 6949579 (2005-09-01), Dutruc-Rosset et al.
patent: 7166629 (2007-01-01), Lesuisse et al.
patent: 7528155 (2009-05-01), Zoller et al.
patent: 7632854 (2009-12-01), Martina et al.
patent: 2008/0312226 (2008-12-01), Matsumoto et al.
patent: 1 813 606 (2007-08-01), None
patent: 03 028720 (2003-04-01), None
patent: 03 035005 (2003-05-01), None
patent: 03 064397 (2003-08-01), None
patent: 03 078403 (2003-09-01), None
patent: 03 097610 (2003-11-01), None
Seddon “Pseudopolymorph . . . ” Crystal growth & design 496) 1087 (2004) (two pages form internet).
Braga et al. “Making crystals from . . . ” J. Royal Soc. chem. Chem. Connun. p. 3635-3645 (2005).
Office Action issued Oct. 14, 2010, in German Patent Application No. 05 710 048.9-1211.
Mochizuki Mami
Nakajo Masahiro
Nakamura Hideo
Oshima Hisae
Takemiya Akihiro
Chang Celia
Mitsubishi Tanabe Pharma Corporation
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Indazole compound and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole compound and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compound and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2661853